Epilepsy in fragile X syndrome

Developmental Medicine and Child Neurology

Volumn 44, Issue 11, 2002, Pages 724-728

  Berry Kravis, Elizabeth ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; FRAGILE X MENTAL RETARDATION PROTEIN; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TIAGABINE; VALPROIC ACID;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FOCAL EPILEPSY; FRAGILE X SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL EXCITABILITY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SEIZURE; SEIZURE SUSCEPTIBILITY; SIDE EFFECT; SPIKE;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; EPILEPSY, ROLANDIC; FEMALE; FOLLOW-UP STUDIES; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; TREATMENT OUTCOME;

EID: 0036827976     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162201002833     Document Type: Article

References (25)

1. Ashley CT, Wilkinson KD, Reines D, Warren ST. (1993) FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262: 563-6.
2. Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF. (1997) The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology 48: 430-7.
3. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT. (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proceedings of the National Academy of Science, USA 94: 5401-4.
4. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L. (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genetics 4: 335-40.
5. Hagerman RJ. (1996) Physical and behavioral phenotype. In: Hagerman RJ, Cronister A, editors. Fragile X Syndrome: Diagnosis, Treatment and Research. Baltimore, MD: Johns Hopkins University Press. p 3-87.
6. Hagerman RJ, Amiri K, Cronister A. (1991) Fragile X checklist. American Journal of Medical Genetics 38: 283-7.
7. Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP, Kooy F, Willems PJ, Cras P, Kozlowski PB, Swain RA, Weiler IJ, Greenough WT. (2001) Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with the fragile X syndrome: a quantitative examination. American Journal of Medical Genetics 98: 161-7.
8. Kluger G, Bohm I, Laub MC, Waldenmaier C. (1996) Epilepsy and fragile X gene mutations. Pediatric Neurology 15: 358-60.
9. Lachiewicz AM, Spiridigliozzi GA, Gullien CM, Ransford S, Rao K. (1994) Aberrant behaviors of young boys with fragile X syndrome. American Journal of Mental Retardation 98: 568-79.
10. Lachiewicz AM, Dawson DV, Spiridigliozzi GA. (2000) Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males. American Journal of Medical Genetics 92: 229-36.
11. Massa R, de Saint-Martin A, Carcangiu R, Rudolf G, Seegmuller C, Kleitz C, Metz-Lutz MN, Hirsch E, Marescaux C. (2001) EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 57: 1071-9.
12. Musumeci SA, Ferri R, Colognola RM, Neri G, Sanfilippo S, Bergonzi P. (1988) Prevalence of a novel epileptogenic EEG pattern in the Martin-Bell syndrome. American Journal of Medical Genetics 30: 207-12.
13. Musumeci SA, Ferri R, Elia M, Colognola RM, Bergonzi P, Tassinari CA. (1991) Epilepsy and fragile X syndrome: a follow-up study. American Journal of Medical Genetics 38: 511-13.
14. Musumeci SA, Hagerman RJ, Ferri R, Bosco P, Dalla Bernadino B, Tassinari CA, DeSarro GB, Elia M. (1999) Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40: 1092-9.
15. Musumeci SA, Bosco P, Calabrese G, Bakker C, DeSarro GB, Elia M, Ferri R, Oostra BA. (2000) Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41: 19-23.
16. Otsubo H, Chitoku S, Ochi A, Jay V, Rutka JT, Smith ML, Elliott IM, Snead III OC. (2001) Malignant rolandic-sylvian epilepsy in children: diagnosis, treatment and outcomes. Neurology 57: 590-6.
17. Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Nelson DL, Caskey CT. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66: 817-22.
18. Rees M, Diebold U, Parker K, Doose H, Gardiner RM, Whitehouse WP. (1993) Benign childhood epilepsy with centrotemporal spikes and the focal sharp waves is not linked to the fragile X region. Neuropediatrics 4: 211-13.
19. Sabaratnam M, Vroegop PG, Gangadharan SK. (2001) Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure 10: 60-3.
20. Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL. (2001) A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proceedings of the National Academy of Science, USA 98: 8844-9.
21. Singh R, Sutherland GR, Manson J. (1999) Partial seizures with focal epileptogenic electroencephalographic patterns in three related female patients with fragile X syndrome. Journal of Child Neurology 14: 108-12.
22. Turner G, Webb T, Wake S, Robinson H. (1996) Prevalence of fragile X syndrome. American Journal of Medical Genetics 64: 196-7.
23. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen GJB, Blonden LAJ, Riggens GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905-14.
24. Vieregge P, Froster-Iskenius U. (1989) Clinico-neurological investigations in the fra(x) form of mental retardation. Journal of Neurology 236: 85-92.
25. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT. (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proceedings of the National Academy of Science, USA 94: 5395-400.